Vol.

No.

August 14, 2026Aug 14, 2026

Free

DOWNLOAD THE PDF

I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology My mother instilled in me: “Never become a product of your circumstances.”

Cover Story

Free Guest Editorial

I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology

My mother instilled in me: “Never become a product of your circumstances.”

By Lavonté Saunders

My high school experience revolved around constantly worrying about my four younger siblings and mom amidst our normal condition—instability.

Free Guest Editorial

From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma

By Sid Sijbrandij

Book Review Free

What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer

By Sara Willa Ernst and Paul Goldberg

Book Review Free Guest Editorial

From the desk of Kimryn Rathmell: What to read before these beautiful days slip away
My summer reading challenged me to see people, purpose, and complexity in a new way

By W. Kimryn Rathmell

Free Guest Editorial

The defining question of the next decade is not how many drug candidates can be generated, but who decides which ones move forward, and why
Drug development must convene a forum for candid, cross-sector discussion

By Richard L. Schilsky, H. Kim Lyerly, Thomas R. Fleming and Renzo Canetta

Clinical Free Guest Editorial

Like it or not, AI psycho-oncology care is already happening. Urgently needed: An ethical framework
Developers and mental health providers must share the same goal: Safe, equitable, trustworthy, and patient-centered care

By Viktor Clark, Sean M. Dozier, AnnaLynn M. Williams, Cynthia M. Rand and Lee A. Kehoe

Free Sponsored

Remote robotic surgery could redefine access to expert cancer care

By Yuman Fong

Podcast

Raja Flores says oncology is loose with staging jargon, and now “it’s confusing my patients.”

Cancer Policy

Trump’s vaccine executive order draws criticism from medical community, may put cancer populations at risk

Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science

ACS CAN voter poll finds overwhelming support for affordable cancer care, high concern over tobacco usage

In Brief

NRG Oncology names vice chairs and committee members

Michelle Ozbun named associate director for basic research at UNMCCC

Stand Up To Cancer Nicolai Award will fund KRAS-targeted immunotherapy combination for pancreatic cancer

USC researchers award $3.2M NIH grant to study age-related inflammation and cancer

Sethera Therapeutics and Roswell Park receive Breast Cancer Research Program Breakthrough Award from CDMRP

Fred Hutch researchers receive multi-year funding from the V Foundation

Clinical Roundup

Traditional prostate cancer risk factors do not predict hormone therapy benefit, UCLA-led study finds

Half of prostate cancer focal therapy use falls outside current guideline-supported patient groups, study finds

HCC-LIVE consortium publishes treatment framework for hepatocellular carcinoma

Baylor researchers develop drug aimed at overcoming cancer drug resistance

SANRECO phase II study of divesiran in polycythemia vera meets primary endpoint

Drugs & Targets

FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma

FDA advisory committee to vote on GRAIL’s multi-cancer detection test, Galleri

FDA approves companion diagnostic supporting patients with advanced melanoma

CURRENT ISSUE

Recent Issues

I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology

From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma

What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer

From the desk of Kimryn Rathmell: What to read before these beautiful days slip away
My summer reading challenged me to see people, purpose, and complexity in a new way

The defining question of the next decade is not how many drug candidates can be generated, but who decides which ones move forward, and why
Drug development must convene a forum for candid, cross-sector discussion

Like it or not, AI psycho-oncology care is already happening. Urgently needed: An ethical framework
Developers and mental health providers must share the same goal: Safe, equitable, trustworthy, and patient-centered care

Remote robotic surgery could redefine access to expert cancer care

Podcast

Raja Flores says oncology is loose with staging jargon, and now “it’s confusing my patients.”

Cancer Policy

Trump’s vaccine executive order draws criticism from medical community, may put cancer populations at risk

Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science

ACS CAN voter poll finds overwhelming support for affordable cancer care, high concern over tobacco usage

In Brief

NRG Oncology names vice chairs and committee members

Michelle Ozbun named associate director for basic research at UNMCCC

Stand Up To Cancer Nicolai Award will fund KRAS-targeted immunotherapy combination for pancreatic cancer

USC researchers award $3.2M NIH grant to study age-related inflammation and cancer

Sethera Therapeutics and Roswell Park receive Breast Cancer Research Program Breakthrough Award from CDMRP

Fred Hutch researchers receive multi-year funding from the V Foundation

Clinical Roundup

Traditional prostate cancer risk factors do not predict hormone therapy benefit, UCLA-led study finds

Half of prostate cancer focal therapy use falls outside current guideline-supported patient groups, study finds

HCC-LIVE consortium publishes treatment framework for hepatocellular carcinoma

Baylor researchers develop drug aimed at overcoming cancer drug resistance

SANRECO phase II study of divesiran in polycythemia vera meets primary endpoint

Drugs & Targets

FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma

FDA advisory committee to vote on GRAIL’s multi-cancer detection test, Galleri

FDA approves companion diagnostic supporting patients with advanced melanoma

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login